A phase II clinical trial of toripalimab combined with neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma (NEOCRTEC1901)-Reference-Cited by-同舟云学术

A phase II clinical trial of toripalimab combined with neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma (NEOCRTEC1901)

Published:2023-08 Issue: Volume:62 Page:102118
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Chen Rui,Liu Qianwen^ORCID,Li Qiaoqiao,Zhu Yujia,Zhao Lei^ORCID,Liu Shiliang,Chen Baoqing,Liu Mengzhong,Hu Yonghong,Lin Ting,Li Jibin,Chen Jiyang,Lv Yingxin,Fu Jianhua,Xi Mian^ORCID,Yang Hong

Funder

Guangzhou Municipal Science and Technology Project

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

General Medicine

Reference38 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries;Sung;CA Cancer J Clin,2021

2. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

3. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;N Engl J Med,2012

4. Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial;Yang;J Clin Oncol,2018

5. A paradigm shift in cancer immunotherapy: from enhancement to normalization;Sanmamed;Cell,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A narrative review on advances in neoadjuvant immunotherapy for esophageal cancer: Molecular biomarkers and future directions;International Journal of Cancer;2024-09-14

2. Impaired TGF-β signaling via AHNAK family mutations elicits an esophageal cancer subtype with sensitivities to genotoxic therapy and immunotherapy;Cancer Immunology, Immunotherapy;2024-09-05

3. Neoadjuvant radiation target volume definition in esophageal squamous cell cancer: a multicenter recommendations from Chinese experts;BMC Cancer;2024-09-02

4. Recent developments in immunotherapy for gastrointestinal tract cancers;Journal of Hematology & Oncology;2024-08-09

5. Immunotherapy for Resectable Locally Advanced Esophageal Carcinoma;The Annals of Thoracic Surgery;2024-07